China NMPA Inspection - Guangzhou Tengyue Biotechnology Co., Ltd. - September 02, 2019

The National Medical Products Administration (NMPA) issued a public notification on September 2, 2019, announcing an unannounced inspection conducted at Guangzhou Tengyue Biotechnology Co., Ltd. This notification, identified with index number JGXX-2020-2114, signifies a regulatory oversight activity by the Chinese drug administration. While the document confirms the occurrence of such an inspection, it does not provide specific details regarding the exact dates the inspection took place, nor does it enumerate any main violations, findings, or issues discovered during the regulatory assessment. Consequently, information pertaining to any required actions, corrective measures, or the regulatory framework details beyond the NMPA's involvement are not available in this particular notification. The publication primarily serves as an official record of the unannounced regulatory scrutiny applied to Guangzhou Tengyue Biotechnology Co., Ltd. by the NMPA.